Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
Clinical trial NCT00021229 · TERMINATED
Trial details
- NCT number
- NCT00021229
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.